Combination or sequential teriparatide for osteoporosis treatment in denosumab-users: real-world bone mineral density outcomes

The optimal osteoanabolic strategy in denosumab (Dmab)-users remains uncertain. In treatment-naïve patients, Dmab/teriparatide (TPTD) combinations result in dramatic bone mineral density (BMD) gains at the spine and hip. However, BMD outcomes with combination Dmab/TPTD have not been investigated in...

Full description

Saved in:
Bibliographic Details
Main Authors: Shejil KUMAR, Courtney STREETER, Michelle M. MCDONALD, Roderick J. CLIFTON- BLIGH, Matti L. GILD, Christian M. GIRGIS
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Bone Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352187225000245
Tags: Add Tag
No Tags, Be the first to tag this record!